SHH and medulloblastoma: Similarly, in a mouse model of SHH-driven medulloblastoma, rare quiescent Sox2+-marked adult neural stem cells were found to be resistant to anti-mitotic and SHH-targeted therapy and responsible for recurrence after treatment (Vanner et al., 2014).